IAB-101

N/A

Report date: 2023/11/01 09:26:40

Base Information

Drug NameIAB-101

Drug Alias NameIAB-101

ClassificationOther

Mechanisms of ActionComplement C5 inhibitors

TargetsComplement C5

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesImmunAbs Inc

China Registration ClassN/A

Develop Information

Active CompaniesImmunAbs Inc

Inactive CompaniesN/A

Active IndicationsAutoimmune Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A

Related LinksN/A